Stephen R. D. Johnston, MA, PhD, FRCP, is interviewed regarding the published results of the EGF30008 trial of lapatinib plus letrozole in women with hormone receptor–positive, HER2-positive metastatic breast cancer, and how these results may affect clinical practice. View Webcast
This Webcast is available from May 2010 to May 2011.

Javier Cortes, MD, is interviewed by Sunil Verma, MD, MSEd, FRCPC, on important data from the 2009 San Antonio Breast Cancer Symposium and how these results may affect clinical practice. View Webcast
This Webcast is available from January 2010 to January 2011.

John Crown, MD, is interviewed by Sunil Verma, MD, MSEd, FRCPC, on important data from the Joint ECCO 15 - 34th ESMO Multidisciplinary Congress and how these results may affect clinical practice. View Webcast
This Webcast is available from December 2009 to December 2010

Henning Mouridsen, MD, PhD, is interviewed by Joseph Gligorov, MD, on the publication of the results of the BIG 1.98 trial and how these results may affect clinical practice. View Webcast
This Webcast is available from October 2009 to October 2010.

Expert interview with PierFranco Conte, MD, that focuses on important data from the 45th ASCO Annual Meeting  View Webcast

This webcast is available from July 2009 to July 2010.

Expert perspectives with Michele Baccarani, MD, and Hagop Kantarjian, MD, regarding nilotinib for the front-line treatment of Ph+ chronic myeloid leukemia
This Webcast is available from 16 February 2010 to 16 February 2011.

Cora Sternberg, MD, FACP, is interviewed regarding the published results of VEG105192, a randomized double-blind, placebo-controlled, trial evaluating treatment with pazopanib in patients with advanced and/or metastatic renal cell carcinoma who had progressed on one prior cytokine-based systemic therapy and how these results may affect clinical practice. View Webcast
This Webcast is available from July 2010 to July 2011.